Two cases of neural tube defects with dolutegravir use at conception in south Brazil.
Braz J Infect Dis
; 25(2): 101572, 2021.
Article
em En
| MEDLINE
| ID: mdl-33852885
Dolutegravir (DTG) is amongst the most prescribed antiretrovirals worldwide and is recommended as first line regimen in most HIV treatment guidelines. Its use, although infrequently, had been associated to an increased chance of neural tube defects (NTD) in Botswana, Africa. Herein we describe two cases of NTD in women who conceived while taking DTG as part of their antiretroviral treatment in the city of Porto Alegre, Brazil.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Infecções por HIV
/
Defeitos do Tubo Neural
Tipo de estudo:
Guideline
Limite:
Female
/
Humans
País/Região como assunto:
Africa
/
America do sul
/
Brasil
Idioma:
En
Revista:
Braz J Infect Dis
Assunto da revista:
DOENCAS TRANSMISSIVEIS
Ano de publicação:
2021
Tipo de documento:
Article
País de publicação:
Brasil